Literature DB >> 19909789

Heterogeneity of glutamatergic and GABAergic release machinery in cerebral cortex: analysis of synaptogyrin, vesicle-associated membrane protein, and syntaxin.

L Bragina1, S Giovedì, P Barbaresi, F Benfenati, F Conti.   

Abstract

To define whether cortical glutamatergic and GABAergic release machineries can be differentiated on the basis of the nature and amount of proteins they express, we studied the degree of co-localization of synaptogyrin (SGYR) 1 and 3, vesicle-associated membrane protein (VAMP) 1 and 2, syntaxin (STX) 1A and 1B in vesicular glutamate transporter (VGLUT)1-, VGLUT2- and vesicular GABA transporter (VGAT)-positive (+) puncta and synaptic vesicles in the rat cerebral cortex. Co-localization studies showed that SGYR1 and 3 were expressed in about 90% of VGLUT1+, 70% of VGLUT2+ and 80% of VGAT+ puncta; VAMP1 was expressed in approximately 45% of VGLUT1+, 55% of VGLUT2+, and 80% of VGAT+ puncta; VAMP2 in about 95% of VGLUT1+, 75% of VGLUT2+, and 80% of VGAT+ puncta; STX1A in about 65% of VGLUT1+, 30% of VGLUT2+, and 3% of VGAT+ puncta, and STX1B in approximately 45% of VGLUT1+, 35% of VGLUT2+, and 70% of VGAT+ puncta. Immunoisolation studies showed that while STX1A was completely segregated and virtually absent from VGAT synaptic vesicles, STX1B, VAMP1/VAMP2, SGYR1/SGYR3 showed a similar pattern with the highest expression in VGLUT1 immunoisolated vesicles and the lowest in VGAT immunoisolated vesicles. Moreover, we studied the localization of STX1B at the electron microscope and found that a population of axon terminals forming symmetric synapses were STX1B-positive.These results extend our previous observations on the differential expression of presynaptic proteins involved in neurotransmitter release in GABAergic and glutamatergic terminals and indicate that heterogeneity of glutamatergic and GABAergic release machinery can be contributed by both the presence or absence of a given protein in a nerve terminal and the amount of protein expressed by synaptic vesicles. Copyright 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909789     DOI: 10.1016/j.neuroscience.2009.11.009

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  25 in total

1.  Mutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes.

Authors:  Julian Schubert; Aleksandra Siekierska; Mélanie Langlois; Patrick May; Clément Huneau; Felicitas Becker; Hiltrud Muhle; Arvid Suls; Johannes R Lemke; Carolien G F de Kovel; Holger Thiele; Kathryn Konrad; Amit Kawalia; Mohammad R Toliat; Thomas Sander; Franz Rüschendorf; Almuth Caliebe; Inga Nagel; Bernard Kohl; Angela Kecskés; Maxime Jacmin; Katia Hardies; Sarah Weckhuysen; Erik Riesch; Thomas Dorn; Eva H Brilstra; Stephanie Baulac; Rikke S Møller; Helle Hjalgrim; Bobby P C Koeleman; Karin Jurkat-Rott; Frank Lehman-Horn; Jared C Roach; Gustavo Glusman; Leroy Hood; David J Galas; Benoit Martin; Peter A M de Witte; Saskia Biskup; Peter De Jonghe; Ingo Helbig; Rudi Balling; Peter Nürnberg; Alexander D Crawford; Camila V Esguerra; Yvonne G Weber; Holger Lerche
Journal:  Nat Genet       Date:  2014-11-02       Impact factor: 38.330

2.  Differential maturation of vesicular glutamate and GABA transporter expression in the mouse auditory forebrain during the first weeks of hearing.

Authors:  Troy A Hackett; Amanda R Clause; Toru Takahata; Nicholas J Hackett; Daniel B Polley
Journal:  Brain Struct Funct       Date:  2015-07-10       Impact factor: 3.270

3.  Dynamics of subcellular proteomes during brain development.

Authors:  Daniel B McClatchy; Lujian Liao; Ji Hyoung Lee; Sung Kyu Park; John R Yates
Journal:  J Proteome Res       Date:  2012-03-26       Impact factor: 4.466

4.  The sodium-driven chloride/bicarbonate exchanger in presynaptic terminals.

Authors:  Alain C Burette; Richard J Weinberg; Patrick Sassani; Natalia Abuladze; Liyo Kao; Ira Kurtz
Journal:  J Comp Neurol       Date:  2012-05-01       Impact factor: 3.215

5.  Association of GTF2i in the Williams-Beuren syndrome critical region with autism spectrum disorders.

Authors:  Patrick Malenfant; Xudong Liu; Melissa L Hudson; Ying Qiao; Monica Hrynchak; Noémie Riendeau; M Jeannette Hildebrand; Ira L Cohen; Albert E Chudley; Cynthia Forster-Gibson; Elizabeth C R Mickelson; Evica Rajcan-Separovic; M E Suzanne Lewis; Jeanette J A Holden
Journal:  J Autism Dev Disord       Date:  2012-07

6.  Proconvulsant actions of intrahippocampal botulinum neurotoxin B in the rat.

Authors:  S Bröer; D Zolkowska; M Gernert; M A Rogawski
Journal:  Neuroscience       Date:  2013-07-29       Impact factor: 3.590

Review 7.  Synaptic vesicle protein 2: A multi-faceted regulator of secretion.

Authors:  Kristine Ciruelas; Daniele Marcotulli; Sandra M Bajjalieh
Journal:  Semin Cell Dev Biol       Date:  2019-03-21       Impact factor: 7.727

8.  Role of GABA release from leptin receptor-expressing neurons in body weight regulation.

Authors:  Yuanzhong Xu; William G O'Brien; Cheng-Chi Lee; Martin G Myers; Qingchun Tong
Journal:  Endocrinology       Date:  2012-02-14       Impact factor: 4.736

9.  Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.

Authors:  Samantha J Fung; Sinthuja Sivagnanasundaram; Cynthia Shannon Weickert
Journal:  Biol Psychiatry       Date:  2011-01-01       Impact factor: 13.382

10.  Presynaptic inhibition of the release of multiple major central nervous system neurotransmitter types by the inhaled anaesthetic isoflurane.

Authors:  R I Westphalen; K M Desai; H C Hemmings
Journal:  Br J Anaesth       Date:  2012-12-04       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.